Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Core USD Corporate Bond UCITS ETF GBP Hedged Dist

PRUB · LU2621112452 · class UCITS ETF GBP Hedged Dist · GBP · domicile Luxembourg
Bonds · Corporate USD · Broad (all maturities) · North AmericaGBP-hedged share classSFDR art. 6
Index tracked: Bloomberg US Corporate Liquid Issuer Unhedged USD
TER
0.09%+ trans. 0.07%
Fund size
4 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingannual
Duration
7.65 yrslong (>7 years)
Launch 11 Jul 2023 · costs from the KID as of 2 Sept 2026 · 2,895 securities held · 2 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Bloomberg US Corporate Liquid Issuer Index (the “Index”), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Total Return Index : the coupons paid by the Index constituents are included in the index return. Bloomberg US Corporate Liquid Issuer Index is a bond…

Performance since series start (in euro) — base 100

11 Jul 20238 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20242025202611693114
High 116 (6 Jul 2026) · low 93 (19 Oct 2023) · last 114. Past performance is not indicative of future results.

Returns in euro

1 year+0.7%
3 years+15.1%
5 yearsseries too young
10 yearsseries too young
Since series start+13.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)6.52%6.93%
Max drawdown−7.06%−9.96%
Sharpe-1.12-0.18
Sortino-1.29-0.23
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PRUB · LU26211124521
RebalixPRUB · LU2621112452 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+8.16%+8.16%+0.00%
2024+1.36%+1.43%−0.07%

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 97.0%
Rating breakdown (% of fund)
AAA0.9%AA11.5%A43.7%BBB40.9%Not rated0.1%Other2.9%
Maturity breakdown (% of fund)
Short term3.4%2 years8.5%5 years22.5%7 years18.5%10 years13.6%15 years6.6%20 years14.0%30 years13.1%

Distributions · per share, in GBP

Frequency: annual · last 12 months: 0.48 GBP (4.60% of NAV) · last ex-date 9 Dec 2025
YearPaymentsTotal (GBP)Dividend yield
202510.48+4.69%
202410.42+4.00%
202310.09
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 2,895 securities · top-10 weight = 1.5%
Countries (% of fund)
United States87.3%United Kingdom4.1%Canada2.4%Japan1.9%Australia0.9%
Sectors (% of fund)
Financials32.9%Health Care13.3%Communications11.9%Technology9.6%Energy8.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
M790 · Börse Hannover, Tradegate Exchange
+ 3 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU2621112452/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU2621112452/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU2621112452/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU2621112452
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PRUB · LU26211124522